カテゴリ： GlobalData, アメリカ, 企業調査

Zimmer Biomet Holdings Inc (ZBH)：医療機器：M&Aディール及び事業提携情報

◆英語タイトル：Zimmer Biomet Holdings Inc (ZBH) - Medical Equipment - Deals and Alliances Profile
◆商品コード：DATA904C7418
◆発行会社（調査会社）：GlobalData
◆発行日：2018年10月
◆ページ数：143
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Zimmer Biomet Holdings Inc (Zimmer Biomet) is a medical device company with focus on musculoskeletal healthcare. The company designs, manufactures, and markets orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, craniomaxillofacial and thoracic products; office based technologies; dental implants; and related surgical products. Its products and solutions assist in treating patients suffering from disorders or injuries in bones, joints and supporting soft tissues. Zimmer Biomet offers its products to orthopaedic surgeons, neurosurgeons, oral surgeons, other specialists, dentists, hospitals, stocking distributors, healthcare dealers and healthcare purchasing organizations. The company sells its products through direct sales channels and distributors in Americas, Europe, Asia-Pacific, the Middle East and Africa. Zimmer Biomet is headquartered in Warsaw, Indiana, the US.

Zimmer Biomet Holdings Inc (ZBH) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 6
List of Figures 7
Zimmer Biomet Holdings Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 8
Zimmer Biomet Holdings Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 9
Zimmer Biomet Holdings Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 10
Zimmer Biomet Holdings Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 11
Zimmer Biomet Holdings Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 12
Zimmer Biomet Holdings Inc, Medical Equipment, Deal Details 16
Asset Purchase 16
Biomet Completes Acquisition Of Trauma Business Of Depuy Orthopaedics For US$280 Million 16
Johnson & Johnson To Sell Distal Volar Radius System To Biomet 17
Venture Financing 18
Cayenne Medical Raises US$5 Million In Venture Financing 18
Cayenne Medical Raises US$0.2 Million In Venture Financing 19
Lanx Raises US$15 Million In Series C Financing 20
Lanx Raises US$15 Million In Venture Financing 21
Lanx Raises US$0.5 Million In Venture Financing Round 22
MedTech Raises US$6 Million In Venture Financing 23
Knee Creations Raises Additional US$3 Million In Third Tranche Of Venture Financing 24
CD Diagnostics Raises US$2.8 Million In Venture Financing 25
LDR Holding, Developer Of Implantable Spine Systems, Raises US$9.7 Million In Venture Financing 26
Cayenne Medical Raises US$10 Million In Series D Financing 27
CD Diagnostics Raises US$0.28 Million In Venture Financing 28
Private Equity 29
Private Equity Owners Evaluate Options For Biomet Exit 29
Partnerships 30
X-spine Systems Enters into Licensing Agreement with Zimmer Spine 30
Dynatronics Enters into Distribution Agreement with Zimmer MedizinSysteme 31
Zimmer Biomet Enters into Licensing Agreement with Bonutti Technologies 32
BoneSupport Extends Distribution Agreement with Zimmer Biomet 33
Seikagaku Enters into Distribution Agreement with Zimmer Biomet 34
Zimmer Biomet Enters into Distribution Agreement with Nextremity Solutions 35
Zimmer Biomet Enters into Distribution Agreement with CelgenTek Innovations 36
LDR Medical Partners with Poly-Shape 37
Medtech Enters into Distribution Agreement with ICR 38
LDR Holding Enters into Distribution Agreement with Sentio for SentioMMG Nerve Mapping System 39
OrthoSensor Enters Into Co-Marketing Agreement With Zimmer Holdings 40
Titan Spine Enters Into Distribution Agreement With Biomet For Endoskeleton Interbody Fusion Devices 41
Zimmer Spine Enters Into Distribution Agreement With Frontier Medical 42
Zimmer Spine Enters Into Distribution Agreement With SpineCraft 43
Biomet Enters Into Co-Promotion Agreement With OrthoSensor 44
Dfine Enters Into Distribution Agreement With Biomet For StabiliT Vertebral Augmentation System 45
Spinelab Enters Into Distribution Agreement With Biomet For Elaspine 46
Bonesupport Enters Into Distribution Agreement With Biomet For Cerament|Bone Void Filler 47
Equity Offering 48
Zimmer Biomet Raises USD965.4 Million in Public Offering of Shares 48
Zimmer Biomet Raises USD1.28 Billion in Public Offering of Shares 50
LDR Holding Raises USD92 Million in Public Offering of Shares 52
LDR Holding Raises USD36.6 Million in Public Offering of Shares 54
Biomet Files Registration Statement For IPO To Raise Up To US$100 Million 56
Medtech Raises USD27.2 Million in IPO of Shares 57
LDR Holding Completes IPO For US$86.25 Million 58
Debt Offering 60
Zimmer Biomet Raises USD300 Million in Public Offering of 3.7% Notes Due 2023 60
Zimmer Biomet Raises USD450 Million in Public Offering of Notes Due 2021 61
Zimmer Biomet Raises USD532 Million in Public Offering of 1.4% Notes Due 2022 62
Zimmer Biomet Raises USD532 Million in Public Offering of 2.42% Notes Due 2026 63
Medtech Raises USD15 Million in Private Placement of 2% Notes Due 2020 64
Zimmer Raises USD1.5 Billion in Public Offering of 2.7% Notes Due 2020 65
Zimmer Raises USD1.25 Billion in Public Offering of 4.45% Notes Due 2045 67
Zimmer Raises USD500 Million in Public Offering of 1.45% Notes Due 2017 69
Zimmer Raises USD1.15 Billion in Public Offering of 2% Notes Due 2018 71
Zimmer Raises USD750 Million in Public Offering of 3.15% Notes Due 2022 73
Zimmer Raises USD2 Billion in Public Offering of 3.55% Notes Due 2025 75
Zimmer Raises USD500 Million in Public Offering of 4.25% Notes Due 2035 77
Biomet Completes Private Placement Of Notes Due 2020 For US$800 Million 79
Biomet Completes Private Placement Of Notes Due 2020 For US$825 Million 80
Biomet Completes Private Placement Of Senior Notes Due 2020 For US$1,000 Million 81
Asset Transactions 82
LimaCorporate Acquires Unicompartmental Flex Knee and Discovery Elbow System from Zimmer Biomet 82
LimaCorporate Acquires Unicompartmental Flex Knee, Discovery Elbow System and Vanguard from Zimmer and Biomet 83
DJO Global Acquires Certain Assets from Zimmer 84
Smith & Nephew to Acquire Zimmer Unicompartmental High Flex Knee System Rights in the US 85
Acquisition 86
Zimmer Biomet Holdings Acquires RespondWell 86
Zimmer Biomet Acquires Clinical Graphics 87
Zimmer Biomet Acquires CD Diagnostics 88
Zimmer Biomet Acquires 58.7% Stake in Medtech 89
Zimmer Biomet Acquires LDR Holding 91
Zimmer Biomet Acquires Compression Therapy Concepts 93
Zimmer Biomet Acquires Cayenne Medical 94
Zimmer Biomet Acquires Ortho Transmission 95
Zimmer Acquires Biomet for USD14 Billion 96
Zimmer Acquires Etex Holdings 98
Biomet Completes Acquisition Of Lanx, Medical Device Company 99
Zimmer Acquires Normed Medizin-Technik 100
Zimmer Acquires Knee Creations, Orthopedic Device Company 101
CD Diagnostics Acquires 80% Stake In Citrano Medical Labs, Provider Of Clinical Laboratory Testing Services 103
Zimmer Acquires Reconstructive Surgery Devices Maker Synvasive Technology 104
Zimmer Biomet Holdings Inc – Key Competitors 105
Zimmer Biomet Holdings Inc – Key Employees 106
Zimmer Biomet Holdings Inc – Locations And Subsidiaries 108
Head Office 108
Other Locations & Subsidiaries 108
Recent Developments 113
Financial Announcements 113
Jul 27, 2018: Zimmer Biomet announces second auarter 2018 financial results 113
Apr 26, 2018: Zimmer Biomet Reports First Quarter 2018 Financial Results 114
Jan 30, 2018: Zimmer Biomet Announces Fourth Quarter and Full-Year 2017 Results 115
Nov 01, 2017: Zimmer Biomet Reports Third Quarter 2017 Financial Results 116
Jul 27, 2017: Zimmer Biomet Reports Second Quarter 2017 Financial Results 117
Jul 11, 2017: Zimmer Biomet Reports Certain Preliminary Second Quarter 2017 Results 118
Apr 27, 2017: Zimmer Biomet Reports First Quarter 2017 Financial Results 119
Jan 31, 2017: Zimmer Biomet Reports Fourth Quarter and Full-Year 2016 Financial Results 120
Jan 10, 2017: Zimmer Biomet Announces Fourth Quarter and Full-Year 2016 Preliminary Sales Results 121
Corporate Communications 122
Aug 03, 2018: Zimmer Biomet appoints Maria Teresa (Tessa) Hilado and Syed Jafry to board of directors 122
Mar 19, 2018: Zimmer Biomet Appoints Coleman N. Lannum as Senior Vice President of Investor Relations 123
Dec 19, 2017: Zimmer Biomet Announces Appointment of Bryan C. Hanson as President and Chief Executive Officer 124
Jul 11, 2017: Zimmer Biomet Announces Leadership Transition 125
May 19, 2017: Zimmer Biomet Names New General Manager to Lead Global Dental Business 126
Jan 17, 2017: Zimmer Biomet Announces Americas Leadership Transition 127
Legal and Regulatory 128
Aug 27, 2018: Zimmer Biomet Holdings: Warning letter from the U.S. Food and Drug Administration 128
Jun 25, 2018: Zimmer Biomet Update on Warsaw North Campus FDA Inspection 129
May 16, 2018: Zimmer Biomet Statement on Warsaw North Campus FDA Inspection 130
Jun 13, 2017: Zimmer Biomet Holdings Announces Resolution of FDA Warning Letter Related to Its Zhejiang, China Manufacturing Facility 131
Jan 12, 2017: Zimmer Biomet Announces Resolution with DOJ and SEC Regarding Previously Disclosed Legacy Biomet FCPA Matters 132
Government and Public Interest 133
May 21, 2018: Zimmer Biomet Announces Call for Applications for the 2018 Connected Health Innovation Award 133
Product News 134
Mar 06, 2018: Zimmer Biomet Exhibits Product and Service Innovations at AAOS 2018 134
Mar 14, 2017: Zimmer Biomet Showcases New Product Innovation, Novel Digital Health Offering and Robotic Technology at AAOS 2017 136
Feb 07, 2017: Zimmer Biomet Announces the International Release of the Innovative Subchondroplasty Procedure 138
Other Significant Developments 139
Apr 30, 2018: Zimmer Biomet Partners with Faith In Practice to Improve Access to Musculoskeletal Care in Guatemala 139
Apr 18, 2018: Oregon Surgical Institute to Implement Zimmer Biomet Signature Solutions Outpatient Program 140
Feb 08, 2018: Zimmer Biomet’s Rapid Recovery Program Marks Two Decades of Success in Europe 141
Oct 04, 2017: Zimmer Biomet Provides Update on Manufacturing Facilities in Guaynabo and Ponce, Puerto Rico 142
Appendix 143
Methodology 143
About GlobalData 143
Contact Us 143
Disclaimer 143

List of Tables
Zimmer Biomet Holdings Inc, Medical Equipment, Key Facts, 2017 2
Zimmer Biomet Holdings Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Zimmer Biomet Holdings Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 8
Zimmer Biomet Holdings Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 9
Zimmer Biomet Holdings Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 10
Zimmer Biomet Holdings Inc, Deals By Market, 2012 to YTD 2018 11
Zimmer Biomet Holdings Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 12
Biomet Completes Acquisition Of Trauma Business Of Depuy Orthopaedics For US$280 Million 16
Johnson & Johnson To Sell Distal Volar Radius System To Biomet 17
Cayenne Medical Raises US$5 Million In Venture Financing 18
Cayenne Medical Raises US$0.2 Million In Venture Financing 19
Lanx Raises US$15 Million In Series C Financing 20
Lanx Raises US$15 Million In Venture Financing 21
Lanx Raises US$0.5 Million In Venture Financing Round 22
MedTech Raises US$6 Million In Venture Financing 23
Knee Creations Raises Additional US$3 Million In Third Tranche Of Venture Financing 24
CD Diagnostics Raises US$2.8 Million In Venture Financing 25
LDR Holding, Developer Of Implantable Spine Systems, Raises US$9.7 Million In Venture Financing 26
Cayenne Medical Raises US$10 Million In Series D Financing 27
CD Diagnostics Raises US$0.28 Million In Venture Financing 28
Private Equity Owners Evaluate Options For Biomet Exit 29
X-spine Systems Enters into Licensing Agreement with Zimmer Spine 30
Dynatronics Enters into Distribution Agreement with Zimmer MedizinSysteme 31
Zimmer Biomet Enters into Licensing Agreement with Bonutti Technologies 32
BoneSupport Extends Distribution Agreement with Zimmer Biomet 33
Seikagaku Enters into Distribution Agreement with Zimmer Biomet 34
Zimmer Biomet Enters into Distribution Agreement with Nextremity Solutions 35
Zimmer Biomet Enters into Distribution Agreement with CelgenTek Innovations 36
LDR Medical Partners with Poly-Shape 37
Medtech Enters into Distribution Agreement with ICR 38
LDR Holding Enters into Distribution Agreement with Sentio for SentioMMG Nerve Mapping System 39
OrthoSensor Enters Into Co-Marketing Agreement With Zimmer Holdings 40
Titan Spine Enters Into Distribution Agreement With Biomet For Endoskeleton Interbody Fusion Devices 41
Zimmer Spine Enters Into Distribution Agreement With Frontier Medical 42
Zimmer Spine Enters Into Distribution Agreement With SpineCraft 43
Biomet Enters Into Co-Promotion Agreement With OrthoSensor 44
Dfine Enters Into Distribution Agreement With Biomet For StabiliT Vertebral Augmentation System 45
Spinelab Enters Into Distribution Agreement With Biomet For Elaspine 46
Bonesupport Enters Into Distribution Agreement With Biomet For Cerament|Bone Void Filler 47
Zimmer Biomet Raises USD965.4 Million in Public Offering of Shares 48
Zimmer Biomet Raises USD1.28 Billion in Public Offering of Shares 50
LDR Holding Raises USD92 Million in Public Offering of Shares 52
LDR Holding Raises USD36.6 Million in Public Offering of Shares 54
Biomet Files Registration Statement For IPO To Raise Up To US$100 Million 56
Medtech Raises USD27.2 Million in IPO of Shares 57
LDR Holding Completes IPO For US$86.25 Million 58
Zimmer Biomet Raises USD300 Million in Public Offering of 3.7% Notes Due 2023 60
Zimmer Biomet Raises USD450 Million in Public Offering of Notes Due 2021 61
Zimmer Biomet Raises USD532 Million in Public Offering of 1.4% Notes Due 2022 62
Zimmer Biomet Raises USD532 Million in Public Offering of 2.42% Notes Due 2026 63
Medtech Raises USD15 Million in Private Placement of 2% Notes Due 2020 64
Zimmer Raises USD1.5 Billion in Public Offering of 2.7% Notes Due 2020 65
Zimmer Raises USD1.25 Billion in Public Offering of 4.45% Notes Due 2045 67
Zimmer Raises USD500 Million in Public Offering of 1.45% Notes Due 2017 69
Zimmer Raises USD1.15 Billion in Public Offering of 2% Notes Due 2018 71
Zimmer Raises USD750 Million in Public Offering of 3.15% Notes Due 2022 73
Zimmer Raises USD2 Billion in Public Offering of 3.55% Notes Due 2025 75
Zimmer Raises USD500 Million in Public Offering of 4.25% Notes Due 2035 77
Biomet Completes Private Placement Of Notes Due 2020 For US$800 Million 79
Biomet Completes Private Placement Of Notes Due 2020 For US$825 Million 80
Biomet Completes Private Placement Of Senior Notes Due 2020 For US$1,000 Million 81
LimaCorporate Acquires Unicompartmental Flex Knee and Discovery Elbow System from Zimmer Biomet 82
LimaCorporate Acquires Unicompartmental Flex Knee, Discovery Elbow System and Vanguard from Zimmer and Biomet 83
DJO Global Acquires Certain Assets from Zimmer 84
Smith & Nephew to Acquire Zimmer Unicompartmental High Flex Knee System Rights in the US 85
Zimmer Biomet Holdings Acquires RespondWell 86
Zimmer Biomet Acquires Clinical Graphics 87
Zimmer Biomet Acquires CD Diagnostics 88
Zimmer Biomet Acquires 58.7% Stake in Medtech 89
Zimmer Biomet Acquires LDR Holding 91
Zimmer Biomet Acquires Compression Therapy Concepts 93
Zimmer Biomet Acquires Cayenne Medical 94
Zimmer Biomet Acquires Ortho Transmission 95
Zimmer Acquires Biomet for USD14 Billion 96
Zimmer Acquires Etex Holdings 98
Biomet Completes Acquisition Of Lanx, Medical Device Company 99
Zimmer Acquires Normed Medizin-Technik 100
Zimmer Acquires Knee Creations, Orthopedic Device Company 101
CD Diagnostics Acquires 80% Stake In Citrano Medical Labs, Provider Of Clinical Laboratory Testing Services 103
Zimmer Acquires Reconstructive Surgery Devices Maker Synvasive Technology 104
Zimmer Biomet Holdings Inc, Key Competitors 105
Zimmer Biomet Holdings Inc, Key Employees 106
Zimmer Biomet Holdings Inc, Subsidiaries 108

List of Figures
Zimmer Biomet Holdings Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Zimmer Biomet Holdings Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Zimmer Biomet Holdings Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Zimmer Biomet Holdings Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Zimmer Biomet Holdings Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 8
Zimmer Biomet Holdings Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 9
Zimmer Biomet Holdings Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 10
Zimmer Biomet Holdings Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 11

★海外企業調査レポート[Zimmer Biomet Holdings Inc (ZBH)：医療機器：M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Sky Metals Ltd (SKY)：企業の財務・戦略的SWOT分析
    Summary Sky Metals Ltd (Sky Metals) is an upstream oil and gas company that offers acquisition, exploration, production and development of oil and gas properties in the US. The company holds interests in conventional and unconventional oil and gas projects in Australia. It projects explores for coal …
  • Eesti Energia AS：戦略・SWOT・企業財務分析
    Eesti Energia AS - Strategy, SWOT and Corporate Finance Report Summary Eesti Energia AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Integrated Diagnostics Inc-医療機器分野：企業M&A・提携分析
    Summary Integrated Diagnostics Inc (Indi) is a medical device company that develops and distributes blood based molecular diagnostics tests for the healthcare markets. The company provides product such as xpresys lung that helps physicians to diagnose complex diseases with a non-invasive blood test. …
  • Goodrich Petroleum Corp (GDP)：石油・ガス：M&Aディール及び事業提携情報
    Summary Goodrich Petroleum Corp (Goodrich) is an independent oil and gas company. It explores, develops and produces oil and natural gas from properties that include Tuscaloosa Marine Shale in Eastern Louisiana and Southwestern Mississippi, Haynesville Shale trend in north Louisiana and east Texas, …
  • StemBioSys Inc-製薬・医療分野：企業M&A・提携分析
    Summary StemBioSys Inc (StemBioSys) is a biomedical company that concentrates on isolation, expansion and delivery of specialized adult stem cells. The company has developed high performance microenvironment for treating human diseases. Its HPME is an advanced stem cell culture system that creates n …
  • Westar Energy Inc：企業の発電所・SWOT分析2018
    Westar Energy Inc - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees ( …
  • Leonardo UK Ltd：企業の戦略・SWOT・財務情報
    Leonardo UK Ltd - Strategy, SWOT and Corporate Finance Report Summary Leonardo UK Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Arab Orient Insurance Company：企業の戦略・SWOT・財務情報
    Arab Orient Insurance Company - Strategy, SWOT and Corporate Finance Report Summary Arab Orient Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • LifeAssays AB (LIFE B)-医療機器分野：企業M&A・提携分析
    Summary LifeAssays AB (LifeAssays) is a medical device company that develops, manufactures and markets in-vitro diagnostic and veterinary care products. The company provides point-of-care diagnostic testing systems. Its product portfolio includes lifeassays human system and lifeassays veterinary sys …
  • Morinaga & Co. Ltd.：企業の戦略・SWOT・財務情報
    Morinaga & Co. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Morinaga & Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • ManTech International Corporation (MANT)：企業の財務・戦略的SWOT分析
    ManTech International Corporation (MANT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Symrise AG (SY1)：企業の財務・戦略的SWOT分析
    Symrise AG (SY1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Dairygold Co-operative Society Ltd：企業の戦略的SWOT分析
    Dairygold Co-operative Society Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Scynexis Inc (SCYX)：企業の財務・戦略的SWOT分析
    Summary Scynexis Inc (Scynexis) is a pharmaceutical company that discovers, develops and commercializes novel anti-infective for various therapeutic needs. The company provides pipeline products such as SCY-078, is used for invasive fungal infections; SCY-635, is used for the treatment of Hepatitis …
  • Trek 2000 International Ltd. (5AB)：企業の財務・戦略的SWOT分析
    Trek 2000 International Ltd. (5AB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • China Shineway Pharmaceutical Group Ltd (2877)：企業の財務・戦略的SWOT分析
    Summary China Shineway Pharmaceutical Group Ltd (China Shineway) is a pharmaceutical company that offers development, manufacture and sales of Chinese medicines. The company’s products comprise shenmai injection, qingkailing injection, huangqi injection, shuxiening injection, wufu xinnaoqing soft ca …
  • SK Innovation Co., Ltd.：企業の戦略・SWOT・財務分析
    SK Innovation Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary SK Innovation Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Delek US Holdings, Inc.：企業のM&A・事業提携・投資動向
    Delek US Holdings, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Delek US Holdings, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Dollarama Inc：戦略・SWOT・企業財務分析
    Dollarama Inc - Strategy, SWOT and Corporate Finance Report Summary Dollarama Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Huber+Suhner AG (HUBN)：企業の財務・戦略的SWOT分析
    Huber+Suhner AG (HUBN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆